A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus

被引：25
|
作者：
Thondam, S. K. [1 ]
Cuthbertson, D. J. [1 ]
Aditya, B. S. [1 ]
MacFarlane, I. A. [1 ]
Wilding, J. P. [1 ]
Daousi, C. [1 ]
机构：
[1] Univ Liverpool, Dept Obes & Endocrinol, Aintree Univ Hosp NHS Fdn Trust Liverpool, Liverpool L69 3BX, Merseyside, England
来源：
CLINICAL ENDOCRINOLOGY | 2012年 / 77卷 / 04期
关键词：
FOOD-INTAKE; WEIGHT; HUMANS; DAMAGE;
D O I：
10.1111/j.1365-2265.2012.04368.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：635 / 637
页数：3
相关论文
共 50 条
  • [1] Efpeglenatide Glucagon-like peptide 1 (GLP-1) receptor agonist Treatment for type 2 diabetes
    Reid, J.
    Rana, K.
    Segel, S. A.
    Sheikh-Ali, M.
    Choksi, R. R.
    Goldfaden, R. F.
    DRUGS OF THE FUTURE, 2019, 44 (06) : 435 - 441
  • [2] ALBIGLUTIDE Glucagon-Like Peptide GLP-1 Receptor Agonist Treatment of Type 2 Diabetes
    Rosenstock, Julio
    Stewart, Murray W.
    DRUGS OF THE FUTURE, 2010, 35 (09) : 701 - 712
  • [3] Physiology and pathophysiology of glucagon-like peptide-1 (GLP-1): The role of GLP-1 in the pathogenesis of diabetes mellitus, obesity, and stress
    Bojanowska, E
    MEDICAL SCIENCE MONITOR, 2005, 11 (08): : RA271 - RA278
  • [4] Preserved Inhibitory Effect of Glucagon-Like Peptide-1 (GLP-1) on Glucagon Secretion in Type 2 Diabetes Mellitus
    Hare, Kristine J.
    Knop, Filip K.
    Asmar, Meena
    Larsen, Steen
    Madsbad, Sten
    Holst, Jens J.
    Vilsboll, Tina
    DIABETES, 2009, 58 : A372 - A372
  • [5] The human glucagon-like peptide-1 (GLP-1) receptor
    Dillon, JS
    Wheeler, MB
    Leng, XH
    Ligon, BB
    Boyd, AE
    PHYSIOLOGY AND PATHOPHYSIOLOGY OF THE ISLETS OF LANGERHANS, 1997, 426 : 113 - 119
  • [6] The low level of glucagon-like peptide-1 (glp-1) is a risk factor of type 2 diabetes mellitus
    Lastya A.
    Saraswati M.R.
    Suastika K.
    BMC Research Notes, 7 (1)
  • [7] Initiating a Glucagon-like Peptide-1 Receptor Agonist in the Management of Type 2 Diabetes Mellitus
    Gavin, James R., III
    JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION, 2012, 112 (01): : S16 - S21
  • [8] Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology
    D. J. Drucker
    C. F. Rosen
    Diabetologia, 2011, 54 : 2741 - 2744
  • [9] Glucagon-like peptide-1 (GLP-1) receptor agonists, obesity and psoriasis: diabetes meets dermatology
    Drucker, D. J.
    Rosen, C. F.
    DIABETOLOGIA, 2011, 54 (11) : 2741 - 2744
  • [10] Glucagon-like peptide-1 receptor agonist (GLP1-RA) therapy in type 2 diabetes
    Ng, Elisabeth
    Shaw, Jonathan E.
    Wood, Anna
    Maple-Brown, Louise J.
    Hare, Matthew J. L.
    AUSTRALIAN JOURNAL OF GENERAL PRACTICE, 2022, 51 (07) : 513 - 518
12345